A. Akhmetshina

发表

Basic and translational research

Oliver Distler, Georg Schett, G. Schett, 2011 .

Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.

M. Mattson, J. Zwerina, G. Schett, 2011, Arthritis and rheumatism.

Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway

J. Zwerina, G. Schett, O. Distler, 2011, Annals of the rheumatic diseases.

Molecular mechanisms of fibroblast activation in the pathogenesis of systemic sclerosis

G. Schett, A. Akhmetshina, 2009 .

The transcription factor JunD mediates transforming growth factor β-induced fibroblast activation and fibrosis in systemic sclerosis

M. Yaniv, G. Schett, O. Distler, 2011, Annals of the rheumatic diseases.

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

A. Gabrielli, U. Müller-Ladner, A. Tyndall, 2008, Annals of the rheumatic diseases.

The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis

C. Scholtysek, G. Schett, O. Distler, 2012, Annals of the rheumatic diseases.

Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis.

J. Zwerina, G. Schett, O. Distler, 2010, Arthritis and rheumatism.

β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis

B. de Crombrugghe, M. Taketo, G. Schett, 2012, Annals of the Rheumatic Diseases.

Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease

U. Müller-Ladner, D. Huscher, S. Gay, 2011, Annals of the rheumatic diseases.

Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis.

G. Schett, O. Distler, Y. Allanore, 2011, Arthritis & Rheumatism.

Induction of apoptosis in circulating angiogenic cells by microparticles.

D. Pisetsky, S. Gay, G. Schett, 2011, Arthritis and rheumatism.

Decreased lymphatic vessel counts in patients with systemic sclerosis: association with fingertip ulcers.

J. Zwerina, G. Schett, D. Kerjaschki, 2010, Arthritis and rheumatism.

The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model

E. Selvi, S. Lorenzini, M. Galeazzi, 2010, Annals of the rheumatic diseases.

Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis

E. Gianchecchi, P. Lazzerini, P. Capecchi, 2012, Annals of the rheumatic diseases.

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.

J. Zwerina, G. Schett, O. Distler, 2009, Arthritis & Rheumatism.

Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo

S. Gay, J. Zwerina, G. Schett, 2008, Journal of cellular and molecular medicine.

Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis

G. Schett, O. Distler, J. Distler, 2012, Annals of the rheumatic diseases.

Microparticles stimulate angiogenesis by inducing ELR+ CXC-chemokines in synovial fibroblasts

J. Zwerina, G. Schett, O. Distler, 2010, Journal of cellular and molecular medicine.

Platelet-derived serotonin links vascular disease and tissue fibrosis

N. Alenina, S. Gay, J. Zwerina, 2011, The Journal of experimental medicine.

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

Oliver Distler, Georg Schett, O. MacDougald, 2012, Nature Communications.

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.

Oliver Distler, R. Gay, S. Gay, 2010, Arthritis and rheumatism.

Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis

Oliver Distler, Georg Schett, J. Zwerina, 2011, Annals of the rheumatic diseases.

Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis

G. Schett, B. Bennett, O. Distler, 2012, Annals of the rheumatic diseases.

Monocyte Chemoattractant Proteins in the Pathogenesis of Systemic Sclerosis

G. Schett, O. Distler, A. Akhmetshina, 2008 .

The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.

S. Gay, J. Zwerina, G. Schett, 2010, Arthritis and rheumatism.

Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis.

J. Zwerina, G. Schett, O. Distler, 2012, Arthritis and rheumatism.

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.

Oliver Distler, Georg Schett, Nicole Busch, 2009, Arthritis and rheumatism.

Dual inhibition of c‐abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis

Oliver Distler, Georg Schett, S. Gay, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.

Oliver Distler, Georg Schett, Shunichi Shiozawa, 2012, Arthritis and rheumatism.

Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.

Oliver Distler, Georg Schett, J. Zwerina, 2008, Arthritis and rheumatism.

Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis.

J. Zwerina, G. Schett, O. Distler, 2008, Arthritis and rheumatism.

R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway.

L. Joosten, J. David, A. Abo, 2010, Arthritis and rheumatism.

β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis

M. Taketo, G. Schett, O. Distler, 2012, Annals of the rheumatic diseases.

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis.

J. Zwerina, G. Schett, O. Distler, 2009, Arthritis and rheumatism.

Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis.

A. Akhmetshina, G. Schett, O. Distler, 2009, Rheumatology.

Monocyte Chemoattractant Proteins in the Pathogenesis of Systemic Sclerosis

A. Akhmetshina, G. Schett, O. Distler, 2022 .

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

A. Gabrielli, U. Müller-Ladner, A. Tyndall, 2018 .

Basic and translational research

C. Beyer, A. Horn, T. Kireva, 2011 .

Novel Anti-Fibrotic Therapies for Experimental Chronic Graft-Versus-Host Disease.

A. Mackensen, G. Schett, B. Spriewald, 2009 .